» Articles » PMID: 35328216

Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study

Overview
Specialty Radiology
Date 2022 Mar 25
PMID 35328216
Authors
Affiliations
Soon will be listed here.
Abstract

Fatty liver index (FLI) is a simple and useful index that evaluates non-alcoholic fatty liver disease (NAFLD), particularly in large epidemiologic studies. Heart failure (HF) is becoming a burden to public health as the global trend toward an aging society continues. Thus, we investigated the effect of FLI on the incidence of HF using large cohort data from the Korean National Health Insurance health database. Methods and Results: A total of 7,958,538 subjects aged over 19 years without baseline HF (men = 4,142,264 and women = 3,816,274) were included. Anthropometric and biochemical measurements were evaluated. FLI scores were calculated and FLI ≥ 60 was considered as having NAFLD. Hazard ratios (HRs) and 95% confidence intervals (CIs) for HF incidence were analysed using multivariable time-dependent Cox proportional hazard models. During a mean follow up of 8.26 years, 17,104 participants developed HF. The FLI components associated with the incidence of HF and FLI showed a causal relationship with HF; the FLI ≥ 60 group had a higher HR for HF (HR 1.493; 95% CIs 1.41−1.581) than the FLI < 30 group. Subgroup analysis showed that fatty liver (FLI ≥ 60) with age ≥ 65 years or women displayed higher HR for HF than fatty liver with age < 65 or men, respectively. An increase in FLI score significantly increased the HR for HF except for those with a FLI score change from <30 to 30−60. Conclusion: NAFLD defined by FLI and increase in FLI score were associated with the incidence of HF. Further detailed prospective studies are needed.

Citing Articles

Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease.

Chen L, Jing X, Chen X, Xie Y, Chen Y, Cai X Rev Cardiovasc Med. 2024; 25(9):344.

PMID: 39355605 PMC: 11440407. DOI: 10.31083/j.rcm2509344.


The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.

Park S, Park J, Kim H, Lee J, Kwon S, Lee Y Intern Emerg Med. 2024; 20(1):105-117.

PMID: 39235708 DOI: 10.1007/s11739-024-03758-6.


Regarding: LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up.

Zhang F, Li W Ann Med. 2024; 56(1):2350628.

PMID: 38728604 PMC: 11089933. DOI: 10.1080/07853890.2024.2350628.


Long-Term Cumulative Exposure to High γ-Glutamyl Transferase Levels and the Risk of Cardiovascular Disease: A Nationwide Population-Based Cohort Study.

Baek H, Kim B, Lee S, Lim D, Kwon H, Chang S Endocrinol Metab (Seoul). 2023; 38(6):770-781.

PMID: 37926990 PMC: 10764996. DOI: 10.3803/EnM.2023.1726.


Fatty liver index (FLI): more than a marker of hepatic steatosis.

Kaneva A, Bojko E J Physiol Biochem. 2023; 80(1):11-26.

PMID: 37875710 DOI: 10.1007/s13105-023-00991-z.


References
1.
He J, Ogden L, Bazzano L, Vupputuri S, Loria C, Whelton P . Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001; 161(7):996-1002. DOI: 10.1001/archinte.161.7.996. View

2.
Fan J, Kim S, Wong V . New trends on obesity and NAFLD in Asia. J Hepatol. 2017; 67(4):862-873. DOI: 10.1016/j.jhep.2017.06.003. View

3.
Stahl E, Dhindsa D, Lee S, Sandesara P, Chalasani N, Sperling L . Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019; 73(8):948-963. DOI: 10.1016/j.jacc.2018.11.050. View

4.
Chopyk D, Grakoui A . Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology. 2020; 159(3):849-863. PMC: 7502510. DOI: 10.1053/j.gastro.2020.04.077. View

5.
Powell-Wiley T, Poirier P, Burke L, Despres J, Gordon-Larsen P, Lavie C . Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021; 143(21):e984-e1010. PMC: 8493650. DOI: 10.1161/CIR.0000000000000973. View